(Q28269445)

2

0 references

P E Mallet

3

0 references

R J Beninger

4

0 references

Brett S Abrahams

1

0 references

Jeff D Rutherford

2

0 references

Paul E Mallet

3

0 references

Richard J Beninger

European Journal of Pharmacology

4

0 references

language of work or name

English

0 references

publication date

19 February 1998

0 references

February 1998

0 references

published in

0 references

volume

343

0 references

issue

2-3

0 references

page(s)

111-8

0 references

111-118

0 references

cites work

Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Dopamine D1-like receptors and reward-related incentive learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Cocaine self-administration is increased by both D1 and D2 dopamine antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Self-administration of D1 receptor agonists by squirrel monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Dopaminergic substrates of cocaine-induced place conditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Role of noradrenergic and dopaminergic processes in amphetamine self-administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioural screen for antipsychotic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The effect of haloperidol on cocaine self-administration is augmented with repeated administrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Dopamine receptor pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Attenuation by haloperidol of place preference conditioning using food reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Increased Lever Pressing for Amphetamine After Pimozide in Rats: Implications for a Dopamine Theory of Reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8

Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901531-8